Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Positron Emission Tomography01:29

Positron Emission Tomography

4.0K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.

Nature medicine·2026
Same author

Advances and challenges of PET imaging in bladder cancer-An update and future trends.

Seminars in nuclear medicine·2026
Same author

SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Artificial intelligence-based lesion characterization and outcome prediction of prostate cancer on [<sup>18</sup>F]DCFPyL PSMA imaging.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
Same author

National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Erratum: Phase II Study of <sup>177</sup>Lu-DOTATATE for Progressive Metastatic Pheochromocytomas and Paragangliomas: Interim Analysis of Efficacy, Safety, and Biomarkers.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025

相关实验视频

Updated: Jun 8, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

139

更新基于PSMA的前列腺癌成像技术

Esther Mena1, Liza Lindenberg1, Peter L Choyke1

  • 1Molecular Imaging Program. National Cancer Institute, NIH, Bethesda, MD.

Seminars in nuclear medicine
|November 3, 2024
PubMed
概括

前列腺特异性膜抗原 (PSMA) PET成像已经改变了前列腺癌的治疗. 这种先进的成像技术可以更好地检测疾病的传播,对个性化的患者护理和治疗计划至关重要.

科学领域:

  • 在瘤学瘤学.
  • 核医学是一种核医学.
  • 放射学 放射学是一门学科.

背景情况:

  • 前列腺癌 (Pca) 管理受到诊断成像技术的进步的影响.
  • 前列腺特异性膜抗原 (PSMA) PET成像已经成为检测前列腺癌的强大工具.

研究的目的:

  • 审查最近关于前列腺癌PSMAPET成像的文献.
  • 要突出PSMA PET在前列腺癌各个阶段不断变化的作用和临床实用性.

主要方法:

  • 关于前列腺癌PSMAPET成像的最新研究的综合文献综述.
  • 分析不同疾病阶段的诊断灵敏度和临床实用性.

主要成果:

  • PSMA PET成像显示出更高的诊断灵敏度来检测前列腺外疾病.
  • 它的临床实用性在前列腺癌的所有阶段都在增加,从初始诊断到复发.

结论:

  • PSMA PET成像正在彻底改变前列腺癌的检测和管理.
  • 它越来越多地被纳入临床指南,减少对传统成像方法的依赖.

更多相关视频

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.4K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.2K

相关实验视频

Last Updated: Jun 8, 2025

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

139
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.4K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.2K